| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.68B | 37.02B | 31.39B | 27.89B | 23.85B | 18.83B |
| Gross Profit | 18.75B | 20.61B | 18.27B | 16.58B | 13.47B | 10.86B |
| EBITDA | 2.28B | 2.77B | 2.16B | 1.98B | 572.00M | -242.00M |
| Net Income | 1.19B | 1.23B | 1.23B | 1.40B | 277.00M | 1.91B |
Balance Sheet | ||||||
| Total Assets | 10.12B | 11.91B | 11.96B | 10.93B | 9.67B | 9.81B |
| Cash, Cash Equivalents and Short-Term Investments | 2.61B | 3.52B | 4.24B | 4.54B | 3.94B | 4.33B |
| Total Debt | 1.45B | 1.00B | 1.60B | 1.00B | 1.65B | 2.31B |
| Total Liabilities | 6.83B | 7.48B | 7.24B | 5.98B | 5.95B | 6.39B |
| Stockholders Equity | 3.06B | 4.11B | 4.48B | 4.78B | 3.59B | 3.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.59B | 683.00M | 1.47B | 234.00M | 2.22B |
| Operating Cash Flow | 0.00 | 3.14B | 2.13B | 2.23B | 726.00M | 2.35B |
| Investing Cash Flow | 0.00 | -1.63B | -1.49B | -787.00M | -478.00M | -160.00M |
| Financing Cash Flow | 0.00 | -2.24B | -1.05B | -889.00M | -773.00M | -1.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ¥250.36B | 33.85 | 9.66% | 0.55% | 15.12% | 18.16% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥656.23B | 35.05 | 9.53% | 0.55% | 12.02% | 20.18% | |
61 Neutral | ¥204.41B | 37.97 | ― | 0.69% | 10.09% | 22.64% | |
59 Neutral | ¥52.86B | 40.19 | ― | 0.17% | 17.94% | 0.67% | |
57 Neutral | ¥102.42B | 15.35 | ― | 0.37% | 20.01% | 38.88% | |
56 Neutral | ¥1.22T | 31.37 | 15.36% | 0.78% | 11.21% | 9.99% |